Daiichi Sankyo
-
{
- All
- News
- Videos
-
Sun Pharma Q4 Net Profit Rises 57 Per Cent to Rs 1,587 Crore
Sun Pharmaceutical Industries Ltd, India's third-largest drugmaker by revenue, on Thursday reported a 57 per cent jump in fourth-quarter net profit, slightly above expectations, helped by higher sales in the United States, its largest market.
-
Ranbaxy Posts Loss After Write-Offs on US Import Bans
Drugmaker Ranbaxy Laboratories Ltd, which has agreed to be acquired by Sun Pharmaceutical Industries Ltd for $3.2 billion (Rs 19201.6 crore at $1 = 60.0050 rupees), posted a loss in the March quarter, hit by write-offs related to regulatory sanctions.
-
Daiichi Files Plea in High Court to Vacate Stay on Sun-Ranbaxy Merger
Based on a petition filed by two individual investors, the court on April 25, issued interim 'status quo' orders on the merger process.
-
Supreme Court Asks Andhra High Court to Decide on Ranbaxy-Sun Pharma Merger
Hearing appeals filed by Sun Pharmaceutical, Ranbaxy Laboratories and Daiichi Sankyo Company against HC interim order, a bench of justices B S Chauhan and A K Sikri asked the HC to decide the issue and posted the case for hearing on May 27.
-
Ranbaxy up; Nod to Generic Version of Novartis Drug
Ranbaxy Laboratories rose 5.8 per cent in early trading after the US Food and Drug Administration (FDA) on Thursday said it has approved the company's generic version of Novartis AG's blood pressure drug Diovan.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Fortis Healthcare Tells Court SEBI Asked Them To Recover Money From Singh Brothers
FHL made submission in recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers.
-
Singh Brothers Diverted Funds Despite Court Orders, Daiichi Sankyo Tells Supreme Court
Daiichi Sankyo said Singh brothers diverted funds despite several orders asking them to maintain stakes in Fortis Healthcare.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal
AstraZeneca was considering a share sale in the past as it was seeking to strengthen drug investments and its balance sheet.
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Supreme Court Order Doesn’t Impact 31.1% Stake Sale To IHH Healthcare: Fortis
IHH’s proposed open offer to acquire an additional 26% in Fortis is scheduled to be launched from Dec. 18 to Jan. 1.
-
Sun Pharma Q4 Net Profit Rises 57 Per Cent to Rs 1,587 Crore
Sun Pharmaceutical Industries Ltd, India's third-largest drugmaker by revenue, on Thursday reported a 57 per cent jump in fourth-quarter net profit, slightly above expectations, helped by higher sales in the United States, its largest market.
-
Ranbaxy Posts Loss After Write-Offs on US Import Bans
Drugmaker Ranbaxy Laboratories Ltd, which has agreed to be acquired by Sun Pharmaceutical Industries Ltd for $3.2 billion (Rs 19201.6 crore at $1 = 60.0050 rupees), posted a loss in the March quarter, hit by write-offs related to regulatory sanctions.
-
Daiichi Files Plea in High Court to Vacate Stay on Sun-Ranbaxy Merger
Based on a petition filed by two individual investors, the court on April 25, issued interim 'status quo' orders on the merger process.
-
Supreme Court Asks Andhra High Court to Decide on Ranbaxy-Sun Pharma Merger
Hearing appeals filed by Sun Pharmaceutical, Ranbaxy Laboratories and Daiichi Sankyo Company against HC interim order, a bench of justices B S Chauhan and A K Sikri asked the HC to decide the issue and posted the case for hearing on May 27.
-
Ranbaxy up; Nod to Generic Version of Novartis Drug
Ranbaxy Laboratories rose 5.8 per cent in early trading after the US Food and Drug Administration (FDA) on Thursday said it has approved the company's generic version of Novartis AG's blood pressure drug Diovan.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Fortis Healthcare Tells Court SEBI Asked Them To Recover Money From Singh Brothers
FHL made submission in recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers.
-
Singh Brothers Diverted Funds Despite Court Orders, Daiichi Sankyo Tells Supreme Court
Daiichi Sankyo said Singh brothers diverted funds despite several orders asking them to maintain stakes in Fortis Healthcare.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal
AstraZeneca was considering a share sale in the past as it was seeking to strengthen drug investments and its balance sheet.
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Supreme Court Order Doesn’t Impact 31.1% Stake Sale To IHH Healthcare: Fortis
IHH’s proposed open offer to acquire an additional 26% in Fortis is scheduled to be launched from Dec. 18 to Jan. 1.
